Preemptive Treatment for Cytomegalovirus Infection in Solid Organ and Bone Marrow Transplant Patients

Co-Sponsor: MCG

Contact Hours: 1.0

ACPE No: 014-999-09-013-L01-P

Activity Type:

Release Date:
Expiration Date:

Learning Objectives

Upon completion of this activity the participant should be able to:
At the conclusion of this knowledge based activity, the participant should be able to:

1.Describe incidence of cytomegalovirus (CMV) infection in the general population
2.Describe incidence of and complications from CMV infection in solid organ transplant (SOT) and bone marrow transplant (BMT) patients
3.Describe diagnostic tests available for screening patients in need of preemptive treatment from CMV infection
4. Describe treatment options available for CMV prophylaxis in SOT and BMT patients
5.Critique the efficacy data from clinical trials
6.Determine dose and duration of preemptive treatment for cytomegalovirus infection in SOT and BMT patients

Faculty:

Eva Maciuleviciute, Pharm.D.
PGY1 Resident
MCG/UGA College of Pharmacy

Computer Requirements for Online Courses
PC

• Windows 2000 SE or greater
• Flash Player Plugin 9.0 or later
• Internet Explorer 6.0 or later OR Firefox 2.0 or later
• Sound Card & Speakers
• 800 x 600 Minimum Monitor Resolution (1024 x 768 Recommended)
• Adobe Acrobat Reader for viewing PDF's

MAC

• Mac OS 10.2.8
• Flash Player Plugin 9.0 or greater
• Safari 2.0 or above OR Firefox 2.0 or later
• Sound Card & Speakers
• 800 x 600 Minimum Monitor Resolution (1024 x 768 Recommended)
• Adobe Acrobat Reader for viewing PDF's'

---

The University of Georgia College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.